PD-L1 copy number gain in nonsmall-cell lung cancer defines a new subset of patients for anti PD-L1 therapy.
Ann Oncol
; 27(1): 206-7, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26487587
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Adenocarcinoma
/
B7-H1 Antigen
/
Lung Neoplasms
/
Antineoplastic Agents
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2016
Document type:
Article